Announced
Completed
Synopsis
Durable Capital Partners, a private equity firm, completed the 110m investment in Abcam, a UK biotechnology company. "Today's equity raise provides greater flexibility to invest in the long term growth of our business to support our customers and capture additional market share through organic and inorganic initiatives," Alan Hirzel, Abcam Chief Executive.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Seller Team (3)
Bidder Team (1)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite